Remedent, Inc.
REMI
$0.05
$0.000.00%
Weiss Ratings | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Price History | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 11.11% | |||
60-Day Total Return | 0.00% | |||
90-Day Total Return | 0.00% | |||
Year to Date Total Return | -9.09% | |||
1-Year Total Return | 0.00% | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -36.71% | |||
52-Week Low % Change | 150.00% | |||
Price | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.08 | |||
52-Week Low Price | $0.02 | |||
52-Week Low Price (Date) | Mar 18, 2024 | |||
52-Week High Price (Date) | Mar 18, 2024 | |||
Valuation | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 963.65K | |||
Enterprise Value | 933.56K | |||
Price/Earnings (TTM) | 5.15 | |||
Earnings Per Share (TTM) | 0.01 | |||
Earnings Per Share Growth | -119.56% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 3.09 | |||
Price/Book (Q) | -- | |||
Enterprise Value/Revenue (TTM) | 2.88 | |||
Price | $0.05 | |||
Enterprise Value/EBITDA (TTM) | 22.66 | |||
Enterprise Value/EBIT | 233.39 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 20.00M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 32 9 241 58 80 | |||
Address | -- | |||
Website | www.remedent.com | |||
Country | Belgium | |||
Year Founded | 1986 | |||
Profitability | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 1.23% | |||
Profit Margin | 2.49% | |||
Management Effectiveness | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 0.05% | |||
Return on Equity | 0.23% | |||
Income Statement | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 324.50K | |||
Total Revenue (TTM) | 324.50K | |||
Revenue Per Share | $0.02 | |||
Gross Profit (TTM) | 160.90K | |||
EBITDA (TTM) | 41.20K | |||
EBIT (TTM) | 4.00K | |||
Net Income (TTM) | 8.10K | |||
Net Income Avl. to Common (TTM) | 8.10K | |||
Total Revenue Growth (Q YOY) | 3.47% | |||
Earnings Growth (Q YOY) | -124.22% | |||
EPS Diluted (TTM) | 0.01 | |||
EPS Diluted Growth (Q YOY) | 123.50% | |||
Balance Sheet | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.80K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 2.51M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 3.61M | |||
Current Ratio (Q) | 1.896 | |||
Book Value Per Share (Q) | -- | |||
Total Assets (Q) | 4.98M | |||
Total Current Liabilities (Q) | 1.32M | |||
Total Debt (Q) | 0.00 | |||
Total Liabilities (Q) | 1.37M | |||
Total Common Equity (Q) | 3.61M | |||
Cash Flow | REMI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -2.70K | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -31.40K | |||
Levered Free Cash Flow (TTM) | 135.10K | |||
Cash from Operations (TTM) | 184.10K | |||